MX2007007029A - Derivados de difenilurea utiles como activadores del canal de potasio. - Google Patents

Derivados de difenilurea utiles como activadores del canal de potasio.

Info

Publication number
MX2007007029A
MX2007007029A MX2007007029A MX2007007029A MX2007007029A MX 2007007029 A MX2007007029 A MX 2007007029A MX 2007007029 A MX2007007029 A MX 2007007029A MX 2007007029 A MX2007007029 A MX 2007007029A MX 2007007029 A MX2007007029 A MX 2007007029A
Authority
MX
Mexico
Prior art keywords
phenyl
urea
carbonyl
tetrazol
amino
Prior art date
Application number
MX2007007029A
Other languages
English (en)
Spanish (es)
Inventor
Palle Christophersen
Bjarne H Dahl
Joachim Demnitz
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of MX2007007029A publication Critical patent/MX2007007029A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2007007029A 2004-12-17 2005-12-14 Derivados de difenilurea utiles como activadores del canal de potasio. MX2007007029A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401953 2004-12-17
US63777504P 2004-12-22 2004-12-22
PCT/EP2005/056766 WO2006064015A2 (en) 2004-12-17 2005-12-14 Diphenylurea derivatives useful as potassium channel activators

Publications (1)

Publication Number Publication Date
MX2007007029A true MX2007007029A (es) 2007-08-08

Family

ID=36354109

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007029A MX2007007029A (es) 2004-12-17 2005-12-14 Derivados de difenilurea utiles como activadores del canal de potasio.

Country Status (8)

Country Link
US (1) US20070293553A1 (cg-RX-API-DMAC7.html)
EP (1) EP1827411A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008524158A (cg-RX-API-DMAC7.html)
CN (1) CN101287456A (cg-RX-API-DMAC7.html)
AU (1) AU2005315607A1 (cg-RX-API-DMAC7.html)
CA (1) CA2591616A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007007029A (cg-RX-API-DMAC7.html)
WO (1) WO2006064015A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1805942B (zh) * 2003-06-17 2010-06-02 神经研究公司 二苯基脲衍生物及其作为氯离子通道阻断剂的用途
WO2006089871A2 (en) * 2005-02-23 2006-08-31 Neurosearch A/S Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
EP2121640A1 (en) * 2007-01-18 2009-11-25 NeuroSearch AS Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
WO2008135591A1 (en) * 2007-05-08 2008-11-13 Neurosearch A/S Novel benzamidine derivatives useful as potassium channel modulators
EP2148868A1 (en) 2007-05-15 2010-02-03 NeuroSearch A/S Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
WO2011053468A1 (en) * 2009-10-30 2011-05-05 Sanofi-Aventis Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
ES2770374T3 (es) 2016-05-17 2020-07-01 Scandion Oncology As Tratamiento combinado de cáncer
JP7111359B2 (ja) * 2018-02-08 2022-08-02 国立大学法人東北大学 植物のカリウムイオン輸送体の機能制御剤及び植物の育成方法
AU2022414087A1 (en) * 2021-12-14 2024-08-01 Trustees Of Tufts College Use of hyperpolarizing agents alone and in combination with other therapeutic agents for treating cancers including glioblastoma
TW202337446A (zh) * 2022-01-28 2023-10-01 韓商鐘根堂股份有限公司 用於預防或治療肺動脈高血壓之組合物
CN117229258B (zh) * 2022-06-07 2024-07-19 杭州壹瑞医药科技有限公司 N-四唑基芳基脲类衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080112A1 (en) * 2001-06-22 2005-04-14 Madsen Lars Siim Compounds for use in disorders associated with mast cell or basophil acitvity
CA2495284A1 (en) * 2002-09-05 2004-03-18 Neurosearch A/S Diarylurea derivatives and their use as chloride channel blockers
US7521480B2 (en) * 2002-11-21 2009-04-21 Neurosearch Aryl ureido benzoic acid derivatives and their use
CN1805942B (zh) * 2003-06-17 2010-06-02 神经研究公司 二苯基脲衍生物及其作为氯离子通道阻断剂的用途
CN1845726A (zh) * 2003-09-04 2006-10-11 波塞东医药公司 用于治疗心脏心律失常的erg通道开放剂
WO2005023238A1 (en) * 2003-09-04 2005-03-17 Poseidon Pharmaceuticals A/S Erg channel openers for the treatment of hyperexcitability-related neuronal diseases

Also Published As

Publication number Publication date
AU2005315607A1 (en) 2006-06-22
JP2008524158A (ja) 2008-07-10
WO2006064015A3 (en) 2006-08-03
CN101287456A (zh) 2008-10-15
WO2006064015A2 (en) 2006-06-22
EP1827411A2 (en) 2007-09-05
CA2591616A1 (en) 2006-06-22
US20070293553A1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
RU2197482C2 (ru) Замещенные фенильные производные, способ их получения, содержащая их фармацевтическая композиция и способ лечения (варианты)
DE60012751T2 (de) Verwendung von EP 4 Rezeptorliganden zur Behandlung von neuropathischem Schmerz
JP2003246773A (ja) 置換されたフェニル誘導体、その製造方法及びその使用方法
RS55651B1 (sr) Nove 5-aminotetrahidrohinolin-2-karbonske kiseline i njihova upotreba
US20070293553A1 (en) Diphenylurea Derivatives Useful As Potassium Channel Activators
CN101990434A (zh) 用于治疗沙粒病毒感染的抗病毒药物
WO2006089871A2 (en) Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
US20110183995A1 (en) Eltoprazine for suppression of l-dopa induced dyskinesias
JP2013506716A (ja) クロフェレマーなどのプロアントシアニジンオリゴマーを用いて疾患を治療する方法
JP2006507329A (ja) 新規アリールウレイド安息香酸誘導体及びその使用
JP2002532414A (ja) 移植片拒絶反応を防止するためのmek阻害剤の使用
US7985761B2 (en) Diphenylurea derivatives and their use as chloride channel blockers or BKCa channel modulators
AU2013283488A1 (en) A phenyl triazole derivative and its use for modulating the GABAA receptor complex
WO2004012733A2 (en) Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
KR20210062023A (ko) Crac 억제제 및 코르티코스테로이드를 포함하는 조성물 및 그의 사용 방법
CA2537746A1 (en) Erg channel openers for the treatment of cardiac arrhythmias
US7691891B2 (en) Diphenylurea derivatives and their use as chloride channel blockers
JP2004520396A (ja) 過剰な又は不十分な細胞死によって特徴づけられる疾患の治療
WO2005023238A1 (en) Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
US8791110B2 (en) Anti-arenaviral compounds
WO1996003398A1 (en) Hemoregulatory compounds
HK1130249A (en) Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators
JP2020520933A (ja) 新規な結晶形態
CA2423945A1 (en) Restrainers of airway mucus secretion
WO2004013107A1 (ja) 脊髄損傷による障害の予防及び/又は治療のための医薬

Legal Events

Date Code Title Description
FA Abandonment or withdrawal